Endocrine actions of osteocalcin

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Patti, Aurora ^a   Gennari, Luigi ^a   Merlotti, Daniela ^a   Dotta, Francesco ^a   Nuti, Ranuccio ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALENDRONIC ACID; DENOSUMAB; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; INSULIN RECEPTOR; OSTEOARTICULAR PROTEIN TYROSINE PHOSPHATASE; OSTEOCALCIN; OSTEOPROTEGERIN; PARATHYROID HORMONE; PLACEBO; PROTEIN TYROSINE PHOSPHATASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VITAMIN D; ZOLEDRONIC ACID;

BONE DENSITY; BONE FRAGILITY; BONE GROWTH; CARBOXYLATION AND DECARBOXYLATION; DIABETES MELLITUS; ENERGY EXPENDITURE; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; INSULIN RELEASE; INSULIN SENSITIVITY; LEYDIG CELL; LIPOLYSIS; MALE FERTILITY; METABOLIC SYNDROME X; NONHUMAN; OSTEOBLAST; OSTEOPOROSIS; PANCREAS ISLET BETA CELL; PHYSICAL ACTIVITY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; TESTOSTERONE SYNTHESIS;

EID: 84877997631     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/846480     Document Type: Review

References (83)

1. Razzaque M. S., Osteocalcin: a pivotal mediator or an innocent bystander in energy metabolism? Nephrology Dialysis Transplantation 2011 26 1 42 45 2-s2.0-78650641156 10.1093/ndt/gfq721
2. Hauschka P. V., Lian J. B., Cole D. E., Gundberg C. M., Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiological Reviews 1989 69 3 990 1047 2-s2.0-0024370924 (Pubitemid 19184853)
3. Nielsen-Marsh C. M., Richards M. P., Hauschka P. V., Thomas-Oates J. E., Trinkaus E., Pettitt P. B., Karavanić I., Poinar H., Collins M. J., Osteocalcin protein sequences of Neanderthals and modern primates. Proceedings of the National Academy of Sciences of the United States of America 2005 102 12 4409 4413 2-s2.0-15444370459 10.1073/pnas.0500450102 (Pubitemid 40397125)
4. Villafán-Bernal J. R., Sánchez-Enríquez S., Muñoz-Valle J. F., Molecular modulation of osteocalcin and its relevance in diabetes. International Journal of Molecular Medicine 2011 28 283 293
5. Booth S. L., Rajabi A. A., Determinants of vitamin K status in humans. Vitamins and Hormones 2008 78 1 22 2-s2.0-41249102720 10.1016/S0083-6729(07) 00001-5
6. Booth S. L., Centi A., Smith S. R., Gundberg C., The role of osteocalcin in human glucose metabolism: marker or mediator? Nature Reviews Endocrinology 2013 9 1 43 55
7. Mundy G. R., Poser J. W., Chemotactic activity of the γ -carboxyglutamic acid containing protein in bone. Calcified Tissue International 1983 35 2 164 168 2-s2.0-0020527356 (Pubitemid 13127649)
8. Glowacki J., Lian J. B., Impaired recruitment and differentiation of osteoclast progenitors by osteocalcin-deplete bone implants. Cell Differentiation 1987 21 4 247 254 2-s2.0-0023226326 (Pubitemid 17151359)
9. Ducy P., Desbois C., Boyce B., Pinero G., Story B., Dunstan C., Smith E., Bonadio J., Goldstein S., Gundberg C., Bradley A., Karsenty G., Increased bone formation in osteocalcin-deficient mice. Nature 1996 382 6590 448 452 2-s2.0-15844412402 10.1038/382448a0 (Pubitemid 26264860)
10. Ng K. W., Regulation of glucose metabolism and the skeleton. Clinical Endocrinology 2011 75 2 147 155 10.1111/j.1365-2265.2011.04133.x
11. Ducy P., The role of osteocalcin in the endocrine cross-talk between bone remodeling and energy metabolism. Diabetologia 2011 54 6 1291 1297 10.1007/s00125-011-2155-z
12. Karsenty G., Ferron M., The contribution of bone to whole-organism physiology. Nature 2012 481 314 320 10.1038/nature10763
13. Lee N. K., Sowa H., Hinoi E., Ferron M., Ahn J. D., Confavreux C., Dacquin R., Mee P. J., McKee M. D., Jung D. Y., Zhang Z., Kim J. K., Mauvais-Jarvis F., Ducy P., Karsenty G., Endocrine regulation of energy metabolism by the skeleton. Cell 2007 130 3 456 469 2-s2.0-34547690686 10.1016/j.cell.2007.05.047 (Pubitemid 47208519)
14. Mauro L. J., Olmsted E. A., Skrobacz B. M., Mourey R. J., Davis A. R., Dixon J. E., Identification of a hormonally regulated protein tyrosine phosphatase associated with bone and testicular differentiation. Journal of Biological Chemistry 1994 269 48 30659 30667 2-s2.0-0028072616 (Pubitemid 24376554)
15. Dacquin R., Mee P. J., Kawaguchi J., Olmsted-Davis E. A., Gallagher J. A., Nichols J., Lee K., Karsenty G., Smith A., Knock-in of nuclear localised β -galactosidase reveals that the tyrosine phosphatase Ptprv is specifically expressed in cells of the bone collar. Developmental Dynamics 2004 229 4 826 834 2-s2.0-1842457067 10.1002/dvdy.20003 (Pubitemid 38429111)
16. Ferron M., Hinoi E., Karsenty G., Ducy P., Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proceedings of the National Academy of Sciences of the United States of America 2008 105 13 5266 5270 2-s2.0-42449096306 10.1073/pnas.0711119105 (Pubitemid 351738545)
17. Yoshikawa Y., Kode A., Xu L., Mosialou I., Silva B. C., Ferron M., Clemens T. L., Economides A. N., Kousteni S., Genetic evidence points to an osteocalcin-independent influence of osteoblasts on energy metabolism. Journal of Bone and Mineral Research 2011 26 9 2012 2025 10.1002/jbmr.417
18. Fulzele K., Clemens T. L., Novel functions for insulin in bone. Bone 2011 50 2 452 456 2-s2.0-79959930539 10.1016/j.bone.2011.06.018
19. Pun K. K., Lau P., Ho P. W. M., The characterization, regulation, and function of insulin receptors on osteoblast-like clonal osteosarcoma cell line. Journal of Bone and Mineral Research 1989 4 6 853 862 2-s2.0-0024851161 (Pubitemid 20065695)
20. Kream B. E., Smith M. D., Canalis E., Raisz L. G., Characterization of the effect of insulin on collagen synthesis in fetal rat bone. Endocrinology 1985 116 1 296 302 2-s2.0-0021967944 (Pubitemid 15190482)
21. Hahn T. J., Westbrook S. L., Sullivan T. L., Goodman W. G., Halstead L. R., Glucose transport in osteoblast-enriched bone explants: characterization and insulin regulation. Journal of Bone and Mineral Research 1988 3 3 359 365 2-s2.0-0023695654
22. Fulzele K., Riddle R. C., DiGirolamo D. J., Cao X., Wan C., Chen D., Faugere M. C., Aja S., Hussain M. A., Brüning J. C., Clemens T. L., Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 2010 142 2 309 319 2-s2.0-77955082747 10.1016/j.cell.2010.06. 002
23. Merlotti D., Gennari L., Dotta F., Lauro D., Nuti R., Mechanisms of impaired bone strength in type 1 and 2 diabetes. Nutrition, Metabolism and Cardiovascular Diseases 2010 20 9 683 690 2-s2.0-78049407620 10.1016/j.numecd.2010.07.008
24. Blüher M., Michael M. D., Peroni O. D., Ueki K., Carter N., Kahn B. B., Kahn C. R., Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Developmental Cell 2002 3 1 25 38 2-s2.0-0036068133 10.1016/S1534-5807(02)00199-5 (Pubitemid 34778393)
25. Brüning J. C., Michael M. D., Winnay J. N., Hayashi T., Hörsch D., Accili D., Goodyear L. J., Kahn C. R., A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Molecular Cell 1998 2 5 559 569 2-s2.0-0032214652 (Pubitemid 128379082)
26. Ferron M., Wei J., Yoshizawa T., Del Fattore A., DePinho R. A., Teti A., Ducy P., Karsenty G., Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 2010 142 2 296 308 2-s2.0-77955035304 10.1016/j.cell.2010.06.003
27. Scimeca J. C., Franchi A., Trojani C., Parrinello H., Grosgeorge J., Robert C., Jaillon O., Poirier C., Gaudray P., Carle G. F., The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc/oc) mutants. Bone 2000 26 3 207 213 2-s2.0-18344407785 10.1016/S8756-3282(99)00278-1 (Pubitemid 30101642)
28. Ferron M., McKee M. D., Levine R. L., Ducy P., Karsenty G., Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone 2012 50 2 568 575 2-s2.0-79955778335 10.1016/j.bone.2011.04.017
29. Brennan-Speranza T. C., Henneicke H., Gasparini S. J., Blankenstein K. I., Heinevetter U., Cogger V. C., Svistounov D., Zhang Y., Cooney G. J., Buttgereit F., Dunstan C. R., Gundberg C., Zhou H., Seibel M. J., Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism. The Journal of Clinical Investigation 2012 122 11 4172 4189
30. Cousin W., Courseaux A., Ladoux A., Dani C., Peraldi P., Cloning of hOST-PTP: the only example of a protein-tyrosine-phosphatase the function of which has been lost between rodent and human. Biochemical and Biophysical Research Communications 2004 321 1 259 265 2-s2.0-3543044984 10.1016/j.bbrc.2004.06.137
31. Confavreux C. B., Borel O., Lee F., Vaz G., Guyard M., Fadat C., Carlier M. C., Chapurlat R., Karsenty G., Osteoid osteoma is an osteocalcinoma affecting glucose metabolism. Osteoporosis International 2012 23 5 1645 1650 2-s2.0-79959272092 10.1007/s00198-011-1684-0
32. Schwetz V., Pieber T., Obermayer-Pietsch B., The endocrine role of the skeleton: background and clinical evidence. European Journal of Endocrinology 2012 166 6 959 967 10.1530/EJE-12-0030
33. Im J. A., Yu B. P., Jeon J. Y., Kim S. H., Relationship between osteocalcin and glucose metabolism in postmenopausal women. Clinica Chimica Acta 2008 396 1-2 66 69 2-s2.0-50049111403 10.1016/j.cca.2008.07.001
34. Pittas A. G., Harris S. S., Eliades M., Stark P., Dawson-Hughes B., Association between serum osteocalcin and markers of metabolic phenotype. The Journal of Clinical Endocrinology & Metabolism 2009 94 3 827 832 2-s2.0-62349099001 10.1210/jc.2008-1422
35. Kindblom J. M., Ohlsson C., Ljunggren O., Karlsson M. K., Tivesten A., Smith U., Mellström D., Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. Journal of Bone and Mineral Research 2009 24 5 785 791 2-s2.0-65949124446 10.1359/jbmr.081234
36. García-Martín A., Cortés-Berdonces M., Luque-Fernández I., Rozas-Moreno P., Quesada-Charneco M., Muñoz-Torres M., Osteocalcin as a marker of metabolic risk in healthy postmenopausal women. Menopause 2011 18 5 537 541 2-s2.0-79959983497 10.1097/gme.0b013e3181f8565e
37. Hwang Y. C., Jeong I. K., Ahn K. J., Chung H. Y., Circulating osteocalcin level is associated with improved glucose tolerance, insulin secretion and sensitivity independent of the plasma adiponectin level. Osteoporosis International 2011 23 4 1337 1342 2-s2.0-79957963022 10.1007/s00198-011-1679-x
38. Weiler H. A., Lowe J., Krahn J., Leslie W. D., Osteocalcin and vitamin D status are inversely associated with homeostatic model assessment of insulin resistance in Canadian aboriginal and white women: the first nations bone health study. The Journal of Nutritional Biochemistry 2012 24 2 412 418 10.1016/j.jnutbio.2011.12.007
39. Lee S. W., Jo H. H., Kim M. R., You Y. O., Kim J. H., Association between obesity, metabolic risks and serum osteocalcin level in postmenopausal women. Gynecological Endocrinology 2012 28 6 472 477 10.3109/09513590.2011.633660
40. Gravenstein K. S., Napora J. K., Short R. G., Ramachandran R., Carlson O. D., Metter E. J., Ferrucci L., Egan J. M., Chia C. W., Cross-sectional evidence of a signaling pathway from bone homeostasis to glucose metabolism. The Journal of Clinical Endocrinology & Metabolism 2011 96 6 E884 E890 2-s2.0-79956318399 10.1210/jc.2010-2589
41. Ngarmukos C., Chailurkit L. O., Chanprasertyothin S., Hengprasith B., Sritara P., Ongphiphadhanakul B., A reduced serum level of total osteocalcin in men predicts the development of diabetes in a long-term follow-up cohort. Clinical Endocrinology 2012 77 1 42 46 10.1111/j.1365-2265.2011.04215.x
42. Kanazawa I., Yamaguchi T., Yamamoto M., Yamauchi M., Kurioka S., Yano S., Sugimoto T., Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. The Journal of Clinical Endocrinology & Metabolism 2009 94 1 45 49 2-s2.0-58149377704 10.1210/jc.2008-1455
43. Yeap B. B., Chubb S. A. P., Flicker L., McCaul K. A., Ebeling P. R., Beilby J. P., Norman P. E., Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels. European Journal of Endocrinology 2011 163 2 265 272 2-s2.0-78751483429 10.1530/EJE-10-0414e
44. Saleem U., Mosley T. H., Kullo I. J., Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 7 1474 1478 2-s2.0-77953921007 10.1161/ATVBAHA.110.204859
45. Kanazawa I., Yamaguchi T., Tada Y., Yamauchi M., Yano S., Sugimoto T., Serum osteocalcin level is positively associated with insulin sensitivity and secretion in patients with type 2 diabetes. Bone 2011 48 4 720 725 2-s2.0-79952698270 10.1016/j.bone.2010.12.020
46. Bao Y., Zhou M., Lu Z., Li H., Wang Y., Sun L., Gao M., Wei M., Jia W., Serum levels of osteocalcin are inversely associated with the metabolic syndrome and the severity of coronary artery disease in Chinese men. Clinical Endocrinology 2011 75 2 196 201 2-s2.0-79960194357 10.1111/j.1365-2265.2011. 04065.x
47. Iglesias P., Arrieta F., Piñera M., Botella-Carretero J. I., Balsa J. A., Zamarrõn I., Menacho M., Díez J. J., Muñoz T., Vázquez C., Serum concentrations of osteocalcin, procollagen type 1 N-terminal propeptide and β -CrossLaps in obese subjects with varying degrees of glucose tolerance. Clinical Endocrinology 2011 75 2 184 188 2-s2.0-79960152609 10.1111/j.1365-2265.2011.04035.x
48. Tan A., Gao Y., Yang X., Zhang H., Qin X., Mo L., Peng T., Xia N., Mo Z., Low serum osteocalcin level is a potential marker for metabolic syndrome: results from a Chinese male population survey. Metabolism 2011 60 8 1186 1192 2-s2.0-79960554187 10.1016/j.metabol.2011.01.002
49. Oosterwerff M. M., van Schoor N. M., Lips P., Eekhoff E. M., Osteocalcin as a predictor of the metabolic syndrome in older persons: a population-based study. Clinical Endocrinology 2012 78 2 242 247 10.1111/j.1365-2265.2012.04391.x
50. Yamashita T., Okano K., Tsuruta Y., Akiba T., Nitta K., Serum osteocalcin levels are useful as a predictor of cardiovascular events in maintenance hemodialysis patients. International Urology and Nephrology 2012 45 1 207 214 10.1007/s11255-012-0156-6
51. Pennisi P., Signorelli S. S., Riccobene S., Celotta G., Di Pino L., La Malfa T., Fiore C. E., Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. Osteoporosis International 2004 15 5 389 395 2-s2.0-2442566636 10.1007/s00198-003-1550-9 (Pubitemid 38639334)
52. Confavreux C. B., Szulc P., Casey R., Boutroy S., Varennes A., Vilayphiou N., Goudable J., Chapurlat R. D., Higher serum osteocalcin is associated with lower abdominal aortic calcification progression and longer 10-year survival in elderly men of the MINOS cohort. The Journal of Clinical Endocrinology & Metabolism 2013 98 3 1084 1092 10.1210/jc.2012-3426
53. Reyes-Garcia R., Rozas-Moreno P., Jimenez-Moleon J. J., Villoslada M. J., Garcia-Salcedo J. A., Santana-Morales S., Munoz-Torres M., Relationship between serum levels of osteocalcin and atherosclerotic disease in type 2 diabetes. Diabetes & Metabolism 2012 38 1 76 81 10.1016/j.diabet.2011.07.008
54. Kapustin A. N., Shanahan C. M., Osteocalcin: a novel vascular metabolic and osteoinductive factor? Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 10 2169 271 10.1161/ATVBAHA.111.233601
55. Yeap B. B., Chubb S. A. P., Flicker L., McCaul K. A., Ebeling P. R., Hankey G. J., Beilby J. P., Norman P. E., Associations of total osteocalcin with all-cause and cardiovascular mortality in older men: the health in men study. Osteoporosis International 2011 23 2 599 606 2-s2.0-79951960317 10.1007/s00198-011-1586-1
56. 34-/KDR+ progenitor cells as an independent marker for unstable atherosclerosis. European Heart Journal 2012 33 23 2963 2969 10.1093/eurheartj/ehs234
57. Hwang Y. C., Jeong I. K., Ahn K. J., Chung H. Y., The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced β -cell function in middle-aged male subjects. Diabetes/Metabolism Research and Reviews 2009 25 8 768 772 2-s2.0-73349104406 10.1002/dmrr.1045
58. Shea M. K., Gundberg C. M., Meigs J. B., Dallal G. E., Saltzman E., Yoshida M., Jacques P. F., Booth S. L., γ -carboxylation of osteocalcin and insulin resistance in older men and women. The American Journal of Clinical Nutrition 2009 90 5 1230 1235 2-s2.0-70350650807 10.3945/ajcn.2009.28151
59. Kanazawa I., Yamaguchi T., Yamauchi M., Yamamoto M., Kurioka S., Yano S., Sugimoto T., Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporosis International 2011 22 1 187 194 2-s2.0-78651518046 10.1007/s00198-010-1184-7
60. Choi H. J., Yu J., Choi H., An J. H., Kim S. W., Park K. S., Jang H. C., Kim S. Y., Shin C. S., Vitamin K2 supplementation improves insulin sensitivity via osteocalcin metabolism: a placebo-controlled trial. Diabetes Care 2011 34 9 e147 10.2337/dc11-0551
61. Pollock N. K., Bernard P. J., Gower B. A., Gundberg C. M., Wenger K., Misra S., Bassali R. W., Davis C. L., Lower uncarboxylated osteocalcin concentrations in children with prediabetes is associated with β -cell function. Journal of Clinical Endocrinology and Metabolism 2011 96 7 E1092 E1099 2-s2.0-79960090744 10.1210/jc.2010-2731
62. Iki M., Tamaki J., Fujita Y., Kouda K., Yura A., Kadowaki E., Sato Y., Moon J. S., Tomioka K., Okamoto N., Kurumatani N., Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: fujiwara-kyo osteoporosis risk in men (FORMEN) study. Osteoporosis International 2012 23 2 761 770 2-s2.0-79952851894 10.1007/s00198-011-1600-7
63. Polgreen L. E., Jacobs D. R., Nathan B. M., Steinberger J., Moran A., Sinaiko A. R., Association of osteocalcin with obesity, insulin resistance, and cardiovascular risk factors in young adults. Obesity 2012 20 11 2194 2201 10.1038/oby.2012.108
64. Bulló M., Moreno-Navarrete J. M., Fernández-Real J. M., Salas-Salvadó J., Total and undercarboxylated osteocalcin predict changes in insulin sensitivity and β cell function in elderly men at high cardiovascular risk. The American Journal of Clinical Nutrition 2012 95 249 55 10.3945/ajcn.111.016642
65. Okuno S., Ishimura E., Tsuboniwa N., Norimine K., Yamakawa K., Yamakawa T., Shoji S., Mori K., Nishizawa Y., Inaba M., Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients. Osteoporosis International 2012 24 2 605 612 10.1007/s00198-012-2003-0
66. Gundberg C. M., Nieman S. D., Abrams S., Rosen H., Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. Journal of Clinical Endocrinology and Metabolism 1998 83 9 3258 3266 2-s2.0-0031792815 10.1210/jc.83.9.3258 (Pubitemid 28500970)
67. Gundberg C. M., Lian J. B., Booth S. L., Vitamin K-dependent carboxylation of osteocalcin: friend or foe? 2012. Advances in Nutrition 3 2 149 157
68. Maïmoun L., Sultan C., Effect of physical activity on calcium homeostasis and calciotropic hormones: a review. Calcified Tissue International 2009 85 4 277 286 2-s2.0-70349969937 10.1007/s00223-009-9277-z
69. Levinger I., Zebaze R., Jerums G., Hare D. L., Selig S., Seeman E., The effect of acute exercise on undercarboxylated osteocalcin in obese men. Osteoporosis International 2011 22 5 1621 1626 2-s2.0-79955466529 10.1007/s00198-010-1370-7
70. Fernández-Real J. M., Izquierdo M., Ortega F., Gorostiaga E., Gómez-Ambrosi J., Moreno-Navarrete J. M., Frühbeck G., Martínez C., Idoate F., Salvador J., Forga L., Ricart W., Ibañez J., The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. Journal of Clinical Endocrinology and Metabolism 2009 94 1 237 245 2-s2.0-58149380112 10.1210/jc.2008-0270
71. Mokuda S., Okuda Y., Onishi M., Post-menopausal women with rheumatoid arthritis who are treated with raloxifene or alendronate or glucocorticoids have lower serum undercarboxylated osteocalcin levels. Journal of Endocrinological Investigation 2011 35 7 661 664
72. Simm P. J., Johannesen J., Briody J., Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2 years of treatment in children with secondary osteoporosis. Bone 2011 49 5 939 943 10.1016/j.bone.2011.07.031
73. Vestergaard P., Risk of newly diagnosed type 2 diabetes is reduced in users of alendronate. Calcified Tissue International 2011 89 4 265 270 10.1007/s00223-011-9515-z
74. Schwartz A. V., Schafer A. L., Grey A., Vittinghoff E., Palermo L., Lui L. Y., Wallace R. B., Cummings S. R., Black D. M., Bauer D. C., Reid I. R., Effects of antiresorptive therapies on glucose metabolism: results from the FIT, HORIZON-PFT and FREEDOM trials. Journal of Bone and Mineral Research 2013 2013 10.1002/jbmr.1865
75. Schafer A. L., Sellmeyer D. E., Schwartz A. V., Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study). The Journal of Clinical Endocrinology & Metabolism 2011 96 12 E1982 E1989 10.1210/jc.2011-0587
76. Forouhi N. G., Ye Z., Rickard A. P., Khaw K. T., Luben R., Langenberg C., Wareham N. J., Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies. Diabetologia 2012 55 8 2173 2182 10.1007/s00125-012-2544-y
77. Wolden-Kirk H., Overbergh L., Christesen H. T., Brusgaard K., Mathieu C., Vitamin D and diabetes: its importance for β cell and immune function. Molecular and Cellular Endocrinology 2011 347 1-2 106 120 10.1016/j.mce.2011.08. 016
78. Oury F., Sumara G., Sumara O., Ferron M., Chang H., Smith C. E., Hermo L., Suarez S., Roth B. L., Ducy P., Karsenty G., Endocrine regulation of male fertility by the skeleton. Cell 2011 144 5 796 809 2-s2.0-79952289069 10.1016/j.cell.2011.02.004
79. Kirmani S., Atkinson E. J., Melton 3rd L. J., Riggs B. L., Amin S., Khosla S., Relationship of testosterone and osteocalcin levels during growth. Journal of Bone and Mineral Research 2011 26 9 2212 2216 10.1002/jbmr.421
80. Kanazawa I., Tanaka K., Ogawa N., Yamauchi M., Yamaguchi T., Sugimoto T., Undercarboxylated osteocalcin is positively associated with free testosterone in male patients with type 2 diabetes mellitus. Osteoporosis International 2012-2013 24 3 1115 1119
81. Hannemann A., Breer S., Wallaschofski H., Nauck M., Baumeister S. E., Barvencik F., Amling M., Schinke T., Haring R., Keller J., Osteocalcin is associated with testosterone in the general population and selected patients with bone disorders. Andrology 2013 2013 10.1111/j.2047-2927.2012.00044.x
82. Seeman E., Pathogenesis of bone fragility in women and men. The Lancet 2002 359 9320 1841 1850 2-s2.0-0037172407 10.1016/S0140-6736(02)08706-8 (Pubitemid 34607063)
83. Corona G., Monami M., Rastrelli G., Type 2 diabetes mellitus and testosterone: a meta-analysis study. International Journal of Andrology 2011 34 6, part 1 528 540 10.1111/j.1365-2605.2010.01117.x